Effect of PCR-CRISPR/Cas12a on the Early Anti-infective Schemes in Patients With Open Air Pneumonia

计划入组 146 人 · 首次发布于 2019 年 11 月 26 日

Detection of Enterovirus Genotypes by CRISPR Technology

首次发布于 2020 年 9 月 2 日

Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells

计划入组 2 人 · 首次发布于 2023 年 9 月 18 日

EDIT-301

CRISPR-Cas13d(CasRx)

TTX-CRISPR

CRISPR Therapeutics

United States

CRISPR Therapeutics, Inc.

United States

Editas Medicine

United States

Federal Circuit Remands CRISPR Patent Dispute to PTAB in Ongoing Editas Medicine Case

CRISPR-Cas Systems Emerge as Programmable Weapons Against MRSA Biofilms

Editas Medicine Targets 2026 Patient Dosing for In Vivo CRISPR LDL Therapy EDIT-401